Cargando…
High Body Mass Index is Associated with Shorter Retention of Tumor Necrosis Factor-Alpha Blocker Treatment in Rheumatoid Arthritis
PURPOSE: To evaluate the association between body mass index (BMI) and tumor necrosis factor α (TNF-α) blockers retention in patients with rheumatoid arthritis (RA). PATIENTS AND METHODS: This prospective cohort study analyzed data about patients with RA who initiated TNF blockers from the Israeli r...
Autores principales: | Elalouf, Ofir, Lidar, Merav, Reitblat, Tatiana, Zisman, Devy, Balbir-Gurman, Alexandra, Hakakian, Odelia, Mashiach, Tanya, Almog, Ronit, Elkayam, Ori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312506/ https://www.ncbi.nlm.nih.gov/pubmed/34321864 http://dx.doi.org/10.2147/BTT.S290169 |
Ejemplares similares
-
Long-term safety and efficacy of infliximab for the treatment of ankylosing spondylitis
por: Elalouf, Ofir, et al.
Publicado: (2015) -
Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab
por: Furer, Victoria, et al.
Publicado: (2022) -
Treatment with Ixekizumab Following Secukinumab Failure in Patients with Psoriatic Arthritis: Real-Life Experience from a Resistant Population
por: Berman, Julia, et al.
Publicado: (2021) -
Appearance of ANCA – associated vasculitis under Tumor necrosis factor-alpha inhibitors treatment
por: Reitblat, Tatiana, et al.
Publicado: (2013) -
A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vaccinations
por: Kharouf, Fadi, et al.
Publicado: (2023)